The efficacy and safety of long-term systemic acyclovir therapy of neonatal herpes in immunocompetent children

Mavrutenkov, V.V. and Bolbot, Y.K. and Shvaratska, O.V. and Kazatska, O.V. (2019) The efficacy and safety of long-term systemic acyclovir therapy of neonatal herpes in immunocompetent children. Світ медицини та біології =World of medicine and biology, № 1 (67). pp. 69-73. ISSN 2079-8334

[img]
Preview
Text
Маврутенко, Больбот.pdf

Download (174kB) | Preview

Abstract

Medical case histories of two male infants born naturally, in term, who developed neonatal Herpes simplex virus type 2 (HSV-2) infections are discussed. Mothers of both infants presented with signs of vesicular rash in the anogenital area at the time of parturitions. In both cases the presented HSV-2 infection had intranatal transmission route. Clinical course of infection was notable for recurrent vesicular rash with no signs of fever or systemic disorders. Both infants were prescribed continuous systemic acyclovir therapy from the early age for over a year. In both cases long-term course of acyclovir was well tolerated and led to longlasting control of the infection. Therefore such therapeutic regimen might be preferable to the intermittent short-term courses for exacerbations of HSV-1 and HSV-2 infections in infants. Assessment of efficacy and optimal duration of the treatment should be mainly determined by clinical indications.

Item Type: Article
Additional Information: DOI 10.26724/2079-8334-2019-1-67-69
Uncontrolled Keywords: неонатальний герпес, ацикловір, діти, терапія; неонатальный герпес, ацикловир, дети, терапия; neonatal HSV infection, acyclovir, infants, treatment
Subjects: Neonatology
Infectious diseases
Divisions: Departments > Department of Infectious Diseases
Departments > Department of Pediatrics 3 and Neonatology (formerly - Hospital Pediatrics 2 and Neonatology)
Depositing User: Елена Шрамко
Date Deposited: 05 Dec 2019 10:07
Last Modified: 17 May 2021 10:22
URI: http://repo.dma.dp.ua/id/eprint/4638

Actions (login required)

View Item View Item